Literature DB >> 2528339

Accuracy of self-reported disability in patients with parkinsonism.

R G Brown1, B MacCarthy, M Jahanshahi, C D Marsden.   

Abstract

For the patient, the most important aspect of parkinsonism is the degree to which the disease interferes with daily living. The patient's self-report may be the only way in which such information can be obtained. Depression and cognitive impairment, however, may influence that self-report. In the present study, three ratings of disability, from the patient, a relative, and an independent observer, showed high levels of agreement. The patients' cognitive function made a small but significant contribution to the accuracy of their self-report judged against the relative's rating. Depression, however, played no role. Agreement between patients and relatives for individual items on the disability questionnaire was reasonably high. The results suggest that patients with parkinsonism can provide accurate self-report of their level of disability, even in the presence of depression and cognitive impairment.

Entities:  

Mesh:

Year:  1989        PMID: 2528339     DOI: 10.1001/archneur.1989.00520450025014

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  35 in total

1.  Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study.

Authors:  J P van Vugt; S Siesling; M Vergeer; E A van der Velde; R A Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

2.  Validation of 24-hour ambulatory gait assessment in Parkinson's disease with simultaneous video observation.

Authors:  Steven T Moore; Valentina Dilda; Bandar Hakim; Hamish G Macdougall
Journal:  Biomed Eng Online       Date:  2011-09-21       Impact factor: 2.819

Review 3.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Authors:  Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre
Journal:  Mov Disord       Date:  2012-01-24       Impact factor: 10.338

4.  Scales for rating motor impairment in Parkinson's disease: studies of reliability and convergent validity.

Authors:  L Henderson; C Kennard; T J Crawford; S Day; B S Everitt; S Goodrich; F Jones; D M Park
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

5.  A randomised controlled trial of a home based exercise programme to reduce the risk of falling among people with Parkinson's disease.

Authors:  Ann Ashburn; Louise Fazakarley; Claire Ballinger; Ruth Pickering; Lindsay D McLellan; Carolyn Fitton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-21       Impact factor: 10.154

6.  A novel device for continuous monitoring of tremor and other motor symptoms.

Authors:  Luigi Battista; Antonietta Romaniello
Journal:  Neurol Sci       Date:  2018-05-07       Impact factor: 3.307

7.  Development of digital biomarkers for resting tremor and bradykinesia using a wrist-worn wearable device.

Authors:  Nikhil Mahadevan; Charmaine Demanuele; Hao Zhang; Dmitri Volfson; Bryan Ho; Michael Kelley Erb; Shyamal Patel
Journal:  NPJ Digit Med       Date:  2020-01-15

8.  Dynamics of change in self-reported disability among persons with Parkinson's disease after 2 years of follow-up.

Authors:  Tatjana Gazibara; Darija Kisic-Tepavcevic; Marina Svetel; Aleksandra Tomic; Iva Stankovic; Vladimir Kostic; Tatjana Pekmezovic
Journal:  Neurol Sci       Date:  2017-05-13       Impact factor: 3.307

9.  Multidisciplinary rehabilitation for people with Parkinson's disease: a randomised controlled study.

Authors:  D T Wade; H Gage; C Owen; P Trend; C Grossmith; J Kaye
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

10.  The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

Authors:  V Peto; C Jenkinson; R Fitzpatrick; R Greenhall
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.